Literature DB >> 30479866

Impact of clinical and personal data in the dermoscopic differentiation between early melanoma and atypical nevi.

Linda Tognetti1,2, Elisa Cinotti1, Elvira Moscarella3,4, Francesca Farnetani5, Josep Malvehy6, Aimilios Lallas7, Giovanni Pellacani5, Giuseppe Argenziano3,4, Gabriele Cevenini2, Pietro Rubegni1.   

Abstract

BACKGROUND: Differential diagnosis of clinically atypical nevi (aN) and early melanomas (eMM) still represents a challenge even for experienced dermoscopists, as dermoscopy alone is not sufficient to adequately differentiate these equivocal melanocytic skin lesions (MSLs).
OBJECTIVES: The objectives of this study were to investigate what were the most relevant parameters for noninvasive differential diagnosis between eMM and aN among clinical, personal, and dermoscopic data and to evaluate their impact as risk factors for malignancy.
METHODS: This was a retrospective study performed on 450 MSLs excised from 2014 to 2016 with a suspicion of malignancy. Dermoscopic standardized images of the 450 MSLs (300 aN and 150 eMM) were collected and evaluated. Patients' personal data (ie, age, gender, body site, maximum diameter) were also recorded. Dermoscopic evaluations were performed by 5 different experts in dermoscopy blinded to histopathological diagnosis. Fleiss' κ was calculated to measure concordance level between experts in the description of dermoscopic parameters for each MSL. The power of the studied variables in discriminating malignant from benign lesions was also investigated through F-statistics.
RESULTS: The variables age and maximum diameter supplied the highest discriminant power (F = 253 and 227, respectively). Atypical network, blue white veil and white shiny streaks were the most significant dermoscopic patterns suggestive of malignancy (F = 110, 104 and 99.5, respectively). Shiny white streaks was the only dermoscopic parameter to obtain satisfactory concordance value. Gender was not a discriminant factor. The specific statistical weight of clinical and personal data (ie, "patient's age" and "lesion diameter") surpassed those of atypical dermoscopic features.
CONCLUSIONS: The objective clinical and personal data collected here could supply a fundamental contribution in the correct diagnosis of equivocal MSLs and should be included in diagnostic algorithms along with significant dermoscopic features (ie, atypical network, blue-white veil, and shiny white streaks).

Entities:  

Keywords:  atypical nevi; clinical and personal data; dermoscopy; melanoma

Year:  2018        PMID: 30479866      PMCID: PMC6246054          DOI: 10.5826/dpc.0804a16

Source DB:  PubMed          Journal:  Dermatol Pract Concept        ISSN: 2160-9381


Introduction

Dermoscopy is a useful noninvasive diagnostic method for differentiating benign from malignant melanocytic skin lesions (MSLs) [1]. In clinical practice, equivocal MSLs, including early melanomas (eMM), that do not yet exhibit clear-cut atypical features and atypical nevi (aN) showing clinical and dermoscopic features usually associated with malignancy are seen frequently. Early diagnosis of these equivocal MSLs can be challenging even for experienced dermoscopists [2-5]. In daily practice, dermatologists consider a patient’s risk factors that together form a basis for the decision “to leave or to excise” that include lesion dimension, localization, evolution in time, number of nevi, personal/familial history of melanoma, and skin phototype [6-8]. However, only 4 criteria—body site, maximum diameter, age, and sex—represent objective and standardized variables to assess for malignancy. The objective of this study was to define which clinical and personal data are the most relevant risk factors for malignancy and to investigate their impact in the dermoscopic differential diagnosis between eMM and aN.

Methods

A total of 493 atypical MSLs were excised from 2014 to 2016 with suspected malignancy (Figure 1). MSLs localized on the face, palms, and soles were excluded a priori due to their peculiar dermoscopic pattern. After selection for image quality, availability of patient data, and agreement of 3/3 experts on histopathological diagnosis, the final database consisted of 450 standardized dermoscopic micrographs—300 aN and 150 eMM—acquired at 17× magnification. Dermoscopic evaluations were independently performed by 5 experts in dermoscopy. They were asked to assess the presence/absence of a series of 18 dermoscopic structures designed to include only the features most commonly associated with atypical MSLs according to the current in literature. To ensure a thorough, blinded pattern recognition analysis, all experts were unaware of the histopathological diagnosis, clinical and personal data. Then, each one of the 18 selected dermoscopic structures was defined as absent/present within a lesion when 5/5 experts agreed. Overall interobserver agreement was estimated by Fleiss’ κ and its 95% confidence interval (CI). In a second phase, we retrospectively collected 2 clinical data (diameter and body site) and 2 personal data (age and sex) sets for each of the 450 MSLs, obtaining an integrated database of 450 images associated with 18 subjective (ie, dermoscopic data) and 4 objective variables (ie, clinical-personal data). In order to be tested for risk factors for malignancy, they were evaluated both in their original form as 5 whole variables and in their binary-coded form as 42 simple variables. Age and maximum diameter were dichotomized to account for some interesting cut-off values. The lesion site was described according to anatomical criteria and further grouped into 4 body areas according to UV exposure, ie, Group A, chronically photoexposed body sites (head, neck, arms/hands); Group B, frequently photoexposed body sites (thighs, legs, ankle, back of the feet); Group C, seldom photoexposed body sites (shoulders, chest/breast, back); and Group D, rarely photoexposed body sites (abdomen, bottom, side).
Figure 1

Examples of dermoscopically and clinically equivocal MSLs from the case study (polarized dermoscopy, 20×) diagnosed histologically. Atypical nevi exhibiting atypical network (A, B), blue-white veil and shiny white streaks (B). Early melanomas (C, D) showing only irregular dots and globules (C) and irregular pigmented blothes (D). Nevi were excised from the abdomen of a 43-year-old woman (A) and the arm of a 51-year-old man (B). Melanomas were excised from the upper back of an 83-year-old man (C) and a 79-year-old woman (D).

Results

Univariate discriminant analysis of all 47 integrated variables, shown in Table 1, was performed taking the histopathological diagnosis as outcome. Univariate power to discriminate between eMM and aN was quantified by means of F-statistics. Statistical significance (P<0.05) was obtained by 37/47 variables. Taken together, the results of this analysis showed that: 1) age and diameter exhibited the highest discriminant power for eMM when considered as whole or simple variables; 2) the classification of anatomical sites into 4 body area groups according to UV exposure resulted in association with malignancy (eg, body site “head” obtained P>0.05 and F<2.69 as simple variable, but P<0.05 and F=12.1 when as part of Group A, chronically exposed body areas); 3) none of the dermoscopic features reached F>110, demonstrating moderate impact; and 4) as reported in Table 2, agreement between experts was generally poor, with the exception of white shiny streaks (κ =0.418, 95% CI 0.403–0.432) albeit of intermediate level, which was probably due to the clear-cut appearance of this pattern.
TABLE 1

Discriminant analysis showing F-statistics (F) and P-value (P) of all dermoscopic, clinical, and personal variables (47) coded into 38 simple variables, 5 whole variables (bold), and 4 grouped variables (italics)

Integrated VariablesFpIntegrated VariablesFp
Age (years)253.000Atypical vascular pattern (AVP)21.2.000
Maximum Diameter (mm)227.000Shoulders13.7.000
Age cut-off ≥40 years197.000Group C: Seldom exposed sites13.5.000
Age cut-off ≥60 years167.000Hypopigmented areas13.4.000
Maximum diameter cut-off ≥8152.000Blue-gray globules13.3.000
Age cut-off ≥50 years146.000Arms + hands12.6.000
Maximum diameter cut-off ≥5133.000Group A: Chronically exposed sites12.1.001
Maximum diameter cut-off ≥7 mm129.000Group D: Rarely exposed sites9.73.002
Maximum diameter cut-off >10 mm124.000Back7.21.007
Atypical network110.000Anatomical Site6.82.009
Age cut-off ≥30 years108.000Neck6.78.009
Blue-white veil104.000Chest/breast5.68.017
Shiny white streaks99.5.000Ankle + back of the feet5.47.019
Irregular pigmented blotches67.6.000Side4.35.037
Irregular streaks55.6.000Head2.69.102
Pink areas52.3.000Multicolor pattern2.68.06
Blue-white veil >30%47.6.000Broad network2.57.08
White scar-like areas41.1.000Bottom2.55.110
Blue-gray peppering39.2.000Abdomen2.30.130
UV-exposed Body Areas39.2.000Radial streaming2.6.10
Group B: Frequently exposed sites27.9.000Multiple brown dots2.3.12
Legs23.5.000Light brown areas2.1.13
Irregular dots and globules (IDG)22.6.000Gender2.1.28
TABLE 2

Concordance levels of experts (D1–D5) in recognition of dermoscopic structures (only variables that obtained P > 0.05 are shown)

Dermoscopic VariableFleiss’ κ [95% CI]Strength of Agreement
Shiny white streaks0.418 [0.403–0.432]Intermediate
Irregular dots and globules0.375 [0.360–0.389]Poor
Blue-white veil0.334 [0.320–0.349]Poor
Blue-gray globules0.302 [0.287–0.316]Poor
Hypopigmented areas0.297 [0.283–0.312]Poor
Irregular streaks0.254 [0.239–0.268]Poor
Atypical network0.238 [0.224–0.253]Poor
White scar-like areas0.214 [0.200–0.229]Poor
Pigmented areas0.163 [0.148–0.177]Poor
Blue-white veil >300.151 [0.137–0.166]Poor
Atypical vascular pattern0.100 [0.085–0.114]Poor
Blue-gray peppering0.098 [0.084–0.113]Poor
Irregular pigmented blotches0.077 [0.063–0.091]Poor

Conclusions

The method of combining clinical and personal data with dermoscopic variables proved to be highly useful diagnostically in differentiating regressing MM from regressing nevi [8]. Here in this dataset of eMM and aN, the relative impact of dermoscopic structures was moderate and their recognition was confirmed to be a rather subjective and equivocal method with unsatisfactory agreement [1,2]. Our findings are in line with recent epidemiological data in that eMM shows a trend to be increasing in prevalence in the elderly with no gender predominance [5,6], a strong correlation with lesion maximum diameter [7,8], and a moderate correlation with UV exposure (F=39.4). This probably reflects only a fraction of eMM that develop due to UV exposure [5-7]. In conclusion, despite the contemporary presence of an atypical network, blue-white veil, and shiny white streaks within an equivocal MSLs, which may indicate malignancy, the objective clinical and personal data collected could supply a fundamental contribution in the correct diagnosis of equivocal MSLs and should be included in diagnostic algorithms.
  8 in total

1.  The Growing Burden of Invasive Melanoma: Projections of Incidence Rates and Numbers of New Cases in Six Susceptible Populations through 2031.

Authors:  David C Whiteman; Adele C Green; Catherine M Olsen
Journal:  J Invest Dermatol       Date:  2016-02-20       Impact factor: 8.551

2.  Accuracy in melanoma detection: a 10-year multicenter survey.

Authors:  Giuseppe Argenziano; Lorenzo Cerroni; Iris Zalaudek; Stefania Staibano; Rainer Hofmann-Wellenhof; Nicola Arpaia; Renato Marchiori Bakos; Brigitte Balme; Jadran Bandic; Roberto Bandelloni; Alexandra M G Brunasso; Horacio Cabo; David A Calcara; Blanca Carlos-Ortega; Ana Carolina Carvalho; Gabriel Casas; Huiting Dong; Gerardo Ferrara; Raffaele Filotico; Guillermo Gómez; Allan Halpern; Gennaro Ilardi; Akira Ishiko; Gulsen Kandiloglu; Hiroshi Kawasaki; Ken Kobayashi; Hiroshi Koga; Ivanka Kovalyshyn; David Langford; Xin Liu; Ashfaq A Marghoob; Massimo Mascolo; Cesare Massone; Laura Mazzoni; Scott Menzies; Akane Minagawa; Loredana Nugnes; Fezal Ozdemir; Giovanni Pellacani; Stefania Seidenari; Katherine Siamas; Ignazio Stanganelli; William V Stoecker; Masaru Tanaka; Luc Thomas; Philipp Tschandl; Harald Kittler
Journal:  J Am Acad Dermatol       Date:  2011-10-06       Impact factor: 11.527

3.  A risk scoring system for the differentiation between melanoma with regression and regressing nevi.

Authors:  P Rubegni; L Tognetti; G Argenziano; N Nami; G Brancaccio; E Cinotti; C Miracco; M Fimiani; G Cevenini
Journal:  J Dermatol Sci       Date:  2016-04-27       Impact factor: 4.563

4.  A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.

Authors:  Feng Liu; Leona Bessonova; Thomas H Taylor; Argyrios Ziogas; Frank L Meyskens; Hoda Anton-Culver
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-21       Impact factor: 4.693

5.  Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma.

Authors:  Naheed R Abbasi; Molly Yancovitz; Dina Gutkowicz-Krusin; Katherine S Panageas; Martin C Mihm; Paul Googe; Roy King; Victor Prieto; Iman Osman; Robert J Friedman; Darrell S Rigel; Alfred W Kopf; David Polsky
Journal:  Arch Dermatol       Date:  2008-04

6.  Association between tumor size and Breslow's thickness in malignant melanoma: a cross-sectional, multicenter study.

Authors:  David Moreno-Ramírez; Teresa Ojeda-Vila; Juan J Ríos-Martín; Adoración Nieto-García; Lara Ferrándiz
Journal:  Melanoma Res       Date:  2015-10       Impact factor: 3.599

7.  Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.

Authors:  Holger A Haenssle; Nerjes Mograby; Anni Ngassa; Timo Buhl; Steffen Emmert; Michael P Schön; Albert Rosenberger; Hans Peter Bertsch
Journal:  JAMA Dermatol       Date:  2016-03       Impact factor: 10.282

8.  Validity and Reliability of Dermoscopic Criteria Used to Differentiate Nevi From Melanoma: A Web-Based International Dermoscopy Society Study.

Authors:  Cristina Carrera; Michael A Marchetti; Stephen W Dusza; Giuseppe Argenziano; Ralph P Braun; Allan C Halpern; Natalia Jaimes; Harald J Kittler; Josep Malvehy; Scott W Menzies; Giovanni Pellacani; Susana Puig; Harold S Rabinovitz; Alon Scope; H Peter Soyer; Wilhelm Stolz; Rainer Hofmann-Wellenhof; Iris Zalaudek; Ashfaq A Marghoob
Journal:  JAMA Dermatol       Date:  2016-07-01       Impact factor: 10.282

  8 in total
  3 in total

1.  Frequency of Publication of Dermoscopic Images in Inter-observer Studies: A Systematic Review.

Authors:  Sam Polesie; Oscar Zaar
Journal:  Acta Derm Venereol       Date:  2021-12-17       Impact factor: 3.875

2.  Clinical and dermoscopic features of surgically treated melanocytic nevi: a retrospective study of 1046 cases.

Authors:  Qian-Xi Li; David L Swanson; Ping Tu; Shu-Xia Yang; Hang Li
Journal:  Chin Med J (Engl)       Date:  2019-09-05       Impact factor: 2.628

3.  An Updated Algorithm Integrated With Patient Data for the Differentiation of Atypical Nevi From Early Melanomas: the idScore 2021.

Authors:  Linda Tognetti; Alessandra Cartocci; Martina Bertello; Mafalda Giordani; Elisa Cinotti; Gabriele Cevenini; Pietro Rubegni
Journal:  Dermatol Pract Concept       Date:  2022-07-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.